Danaher Corporation Reports Decline in 2023 Revenues Amid Transformational Year

Danaher Corporation reported a 10.0% decrease in revenues for the fourth quarter of 2023 and a 10.5% decrease for the full year 2023. The company's net earnings were $1.1 billion for the fourth quarter and $4.2 billion for the full year. Danaher's President and CEO, Rainer M. Blair, highlighted the company's better-than-expected revenue in each segment and the recent acquisition of Abcam. The company anticipates a high-single digits decline in non-GAAP core revenue for the first quarter of 2024 and a low-single digits decline for the full year 2024. Danaher is a leading global life sciences and diagnostics innovator committed to improving human health through science and technology.